Jamiyan and colleagues reported that infiltration of CD163+ TAMs, rather than CD68+, in both tumor stroma (TS) and tumor nests (TN) was associated with poor prognosis in patients with triple-negative breast cancer (TNBC) [38]. This evidence concerns the gene CD163 and neoplasm.